Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Defining the phenotypical spectrum associated with variants in TUBB2A.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Defining the phenotypical spectrum associated with variants in TUBB2A.
Defining the phenotypical spectrum associated with variants in TUBB2A. J Med Genet. 2021 01; 58(1):33-40.
View in:
PubMed
subject areas
Adolescent
Adult
Brain
Cerebellar Vermis
Child
Child, Preschool
Developmental Disabilities
Female
Genetic Predisposition to Disease
Humans
Intellectual Disability
Male
Mutation, Missense
Nervous System Malformations
Neuroimaging
Phenotype
Polymicrogyria
Tubulin
Young Adult
authors with profiles
William B. Dobyns